Consumer health company Molecular You completed a $5 million Series A round led by Voloridge Health to enhance its blood test platform analyzing over 250 biomarkers for 26 health conditions and develop a next-generation assay covering 800 biomarkers. The Vancouver-based firm recently partnered with HealthQuest Esoterics for laboratory-developed test deployment, enabling reimbursement eligibility. The funding injection supports growth in North American clinical and consumer markets as Molecular You aims to broaden personalized health profiling through advanced metabolomic and proteomic biomarker testing.